Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.

Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW.

JAMA. 1999 Jul 21;282(3):267-70. Erratum in: JAMA 2000 Mar 8;283(10):1293.

PMID:
10422996
2.

On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.

Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, Vroom MB, Smorenburg SM.

Crit Care. 2010;14(5):R174. doi: 10.1186/cc9278. Epub 2010 Oct 4.

3.

Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.

Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA.

Arch Intern Med. 2003 Sep 22;163(17):2014-8.

PMID:
14504113
4.

Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients.

Kaushal R, Bates DW, Abramson EL, Soukup JR, Goldmann DA.

Am J Health Syst Pharm. 2008 Jul 1;65(13):1254-60. doi: 10.2146/ajhp070522.

PMID:
18574016
5.

Incidence of adverse drug events in an academic hospital: a prospective cohort study.

Aljadhey H, Mahmoud MA, Mayet A, Alshaikh M, Ahmed Y, Murray MD, Bates DW.

Int J Qual Health Care. 2013 Dec;25(6):648-55. doi: 10.1093/intqhc/mzt075. Epub 2013 Oct 17.

PMID:
24141014
6.

Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.

Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Brown R, Kim R, Kukreja S, Johnson M, Paris B, Wood KE, Walker J.

BMJ Qual Saf. 2014 Jan;23(1):56-65. doi: 10.1136/bmjqs-2013-001828. Epub 2013 Sep 19.

7.

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al.

JAMA. 1995 Jul 5;274(1):29-34.

PMID:
7791255
8.

Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.

Kopp BJ, Mrsan M, Erstad BL, Duby JJ.

Am J Health Syst Pharm. 2007 Dec 1;64(23):2483-7.

PMID:
18029956
9.

Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.

Jiang SP, Xu YY, Ping-Yang, Wu WF, Zhang XG, Lu XY, Xiao YH, Liang WF, Chen J.

Eur J Intern Med. 2014 Dec;25(10):930-5. doi: 10.1016/j.ejim.2014.08.001. Epub 2014 Aug 18.

PMID:
25153537
10.

Role of pharmacist counseling in preventing adverse drug events after hospitalization.

Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW.

Arch Intern Med. 2006 Mar 13;166(5):565-71.

PMID:
16534045
11.

Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.

Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, Burdick E, Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger DL.

JAMA. 1998 Oct 21;280(15):1311-6.

PMID:
9794308
12.

Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.

Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL.

Crit Care Med. 1997 Aug;25(8):1289-97.

PMID:
9267940
13.

Medication reconciliation for reducing drug-discrepancy adverse events.

Boockvar KS, Carlson LaCorte H, Giambanco V, Fridman B, Siu A.

Am J Geriatr Pharmacother. 2006 Sep;4(3):236-43.

PMID:
17062324
14.

Medication errors and adverse drug events in pediatric inpatients.

Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, Goldmann DA.

JAMA. 2001 Apr 25;285(16):2114-20.

PMID:
11311101
15.

Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.

Overhage JM, Gandhi TK, Hope C, Seger AC, Murray MD, Orav EJ, Bates DW.

J Patient Saf. 2016 Jun;12(2):69-74. doi: 10.1097/PTS.0000000000000194.

PMID:
26001546
16.

Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events.

Mergenhagen KA, Blum SS, Kugler A, Livote EE, Nebeker JR, Ott MC, Signor D, Sung S, Yeh J, Boockvar KS.

Am J Geriatr Pharmacother. 2012 Aug;10(4):242-50. doi: 10.1016/j.amjopharm.2012.06.001. Epub 2012 Jul 20.

PMID:
22819386
17.

Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

Kunac DL, Kennedy J, Austin N, Reith D.

Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005.

PMID:
19301935
18.

Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial.

Kripalani S, Roumie CL, Dalal AK, Cawthon C, Businger A, Eden SK, Shintani A, Sponsler KC, Harris LJ, Theobald C, Huang RL, Scheurer D, Hunt S, Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Bates DW, Williams MV, Schnipper JL; PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group.

Ann Intern Med. 2012 Jul 3;157(1):1-10. doi: 10.7326/0003-4819-157-1-201207030-00003.

19.

Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.

Sakuma M, Ida H, Nakamura T, Ohta Y, Yamamoto K, Seki S, Hiroi K, Kikuchi K, Nakayama K, Bates DW, Morimoto T.

BMJ Qual Saf. 2014 Oct;23(10):830-7. doi: 10.1136/bmjqs-2013-002658. Epub 2014 Apr 17.

PMID:
24742779
20.

Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit.

Jiang SP, Zhu ZY, Ma KF, Zheng X, Lu XY.

Scand J Infect Dis. 2013 Dec;45(12):891-9. doi: 10.3109/00365548.2013.827338. Epub 2013 Sep 12.

PMID:
24024759

Supplemental Content

Support Center